Q08602 (PGTA_RAT) Rattus norvegicus (Rat)
Geranylgeranyl transferase type-2 subunit alpha UniProtKBInterProSTRINGInteractive Modelling
567 aa; Sequence (Fasta) ;
1 identical sequence: Rattus norvegicus: A6KH43
It is possible new templates exist for this target since these models were created.
Available Structures
21 Experimental Structures
| Description | PDB ID | Oligo-state | Range | Ligands | ||
|---|---|---|---|---|---|---|
| CRYSTAL STRUCTURE OF RAB GERANYLGERANYLTRANSFERASE FROM RAT BRAIN |
Heteromer Q08603; | 1×ZN; | ||||
| Assess | ||||||
| Structure of Rab Escort Protein-1 in complex with Rab geranylgeranyl transferase and isoprenoid |
Heteromer P37727; Q08603; | 1×ZN; 1×CL; 1×FAR; | ||||
| Assess | ||||||
| Crystal structure of RabGGTase(DELTA LRR; DELTA IG)in complex with mono-prenylated peptide Ser-Cys(… |
Heteromer Q08603; | 1×ZN; 1×CA; 1×GER; | ||||
| Assess | ||||||
| RabGGTase in complex with covalently bound Psoromic acid |
Heteromer Q08603; | 1×PJA; 1×ZN; 1×CA; | ||||
| Assess | ||||||
| Crystal structure of RabGGTase(DELTA LRR; DELTA IG)in complex with di-prenylated peptide Ser-Cys(GG… |
Heteromer Q08603; | 1×ZN; 1×CA; 1×GER; | ||||
| Assess | ||||||
| Crystal structure of RabGGTase(DELTA LRR; DELTA IG)in complex with mono-prenylated peptide Ser-Cys-… |
Heteromer Q08603; | 1×ZN; 1×CA; 1×GER; | ||||
| Assess | ||||||
| Crystal structure of RabGGTase(DELTA LRR; DELTA IG) |
Heteromer Q08603; | 1×ZN; 2×CA; | ||||
| Assess | ||||||
| Engineered RabGGTase in complex with BMS analogue 16 |
Heteromer Q08603; | 1×ZN; 1×CA; 1×7TP; | ||||
| Assess | ||||||
| Crystal structure of RabGGTase(DELTA LRR; DELTA IG)in complex with geranylgeranyl pyrophosphate |
Heteromer Q08603; | 1×GRG; 1×ZN; 1×CA; | ||||
| Assess | ||||||
| Engineered RabGGTase in complex with BMS analogue 12 |
Heteromer Q08603; | 1×ZN; 1×CA; 1×7TQ; | ||||
| Assess | ||||||
| Engineered RabGGTase in complex with a peptidomimetic inhibitor (compound 6) |
Heteromer Q08603; | 1×BD5; 1×ZN; | ||||
| Assess | ||||||
| Engineered RabGGTase in complex with a peptidomimetic inhibitor (compound 32) |
Heteromer Q08603; | 1×ZN; 1×CA; 1×BD9; | ||||
| Assess | ||||||
| Engineered RabGGTase in complex with BMS analogue 13 |
Heteromer Q08603; | 1×ZN; 1×CA; 1×7TR; | ||||
| Assess | ||||||
| Crystal structure of RabGGTase(DELTA LRR; DELTA IG) in Complex with BMS3 |
Heteromer Q08603; | 1×3PZ; 1×ZN; 1×CA; 4×DMS; | ||||
| Assess | ||||||
| Engineered RabGGTase in complex with a peptidomimetic inhibitor |
Heteromer Q08603; | 1×ZN; 1×CA; 1×CX1; | ||||
| Assess | ||||||
| Crystal structure of RabGGTase(DELTA LRR; DELTA IG) in Complex with BMS3 and lipid substrate GGPP |
Heteromer Q08603; | 1×ZN; 1×CA; 1×3PZ; 1×GRG; | ||||
| Assess | ||||||
| Crystal structure of RabGGTase(DELTA LRR; DELTA IG)in complex with farnesyl pyrophosphate |
Heteromer Q08603; | 1×FPP; 1×ZN; 1×CA; | ||||
| Assess | ||||||
| Engineered RabGGTase in complex with a peptidomimetic inhibitor (compound 9) |
Heteromer Q08603; | 1×ZN; 1×CA; 1×BD7; | ||||
| Assess | ||||||
| Engineered RabGGTase in complex with a peptidomimetic inhibitor (compound 37) |
Heteromer Q08603; | 1×ZN; 1×CA; 1×BD8; | ||||
| Assess | ||||||
| Crystal structure of RabGGTase(DELTA LRR; DELTA IG) in Complex with BMS-analogue 14 |
Heteromer Q08603; | 1×ZN; 1×CA; 1×PZ3; | ||||
| Assess | ||||||
| Engineered RabGGTase in complex with a peptidomimetic inhibitor (compound 8) |
Heteromer Q08603; | 1×ZN; 1×CA; 1×BD6; | ||||
| Assess | ||||||
2 SWISS-MODEL models
| Template | Oligo-state | QMEANDisCo | Range | Ligands | Trg-Tpl Seq id (%) | |
|---|---|---|---|---|---|---|
| 1dce.2.A | monomer | 0.85 | 100.00 | |||
| Assess | ||||||
| 4ui9.1.H | monomer | 0.59 | 12.12 | |||
| Assess | ||||||